Keyphrases
Intrauterine Growth Retardation
99%
Thiamine Deficiency
93%
Spinal muscular Atrophy
90%
Thiamine
82%
Seizure
78%
Epilepsy
70%
Neurodevelopmental Outcome
67%
Neurofibromatosis Type I
59%
Neurofibromatosis Type 1 (NF-1)
59%
Cerebral Palsy children
56%
Nusinersen
50%
Tuberous Sclerosis Complex
49%
Idiopathic Intracranial Hypertension
49%
Spastic Cerebral Palsy
46%
Early Onset
42%
Selective Intrauterine Growth Restriction (sIUGR)
41%
Hemiplegia
36%
Onasemnogene Abeparvovec
32%
Botulinum Neurotoxin (BoNT)
32%
Newborn Screening
32%
Botulinum Toxin Injection
31%
BECTS
31%
Pediatric
31%
TOSCA
30%
Israeli
30%
Pediatric Patients
30%
Israel
30%
Whole Exome Sequencing
29%
Mitochondrial Disease
29%
Acute Disseminated Encephalomyelitis
29%
Hereditary Spastic Paraparesis
29%
Gene Therapy
29%
Motor Function
29%
Magnetic Resonance Imaging
28%
Intellectual Disability
28%
Pseudotumor Cerebri
27%
Gross Motor Function Classification System (GMFCS)
27%
Drug-resistant Epilepsy
27%
Leukoencephalopathy
26%
Spinal muscular Atrophy Type 1
26%
Late-onset
25%
Cerebrospinal Fluid
25%
Assisting Hand Assessment
25%
Leukodystrophy
25%
Clinical Features
25%
Intrauterine Growth
24%
Attention Deficit Hyperactivity Disorder
24%
Typically Developing children
24%
Neurodevelopmental
23%
Founder mutation
23%
Medicine and Dentistry
Intrauterine Growth Retardation
100%
Spastic Diplegia
94%
Epileptic Seizure
71%
Spinal Muscular Atrophy
65%
Magnetic Resonance Imaging
62%
Thiamine Deficiency
62%
Disease
56%
Thiamine
55%
Nusinersen
40%
Botulinum Toxin
39%
Botulinum Toxin A
37%
Hemiplegia
35%
Prospective Study
35%
Pediatrics
34%
Motor Performance
31%
Cerebrospinal Fluid
30%
Acute Disseminated Encephalomyelitis
29%
Upper Limb
29%
Gene Therapy
29%
Infancy
27%
Werdnig Hoffmann Disease
26%
Cerebral Hemorrhage
25%
Neonatal Infant
23%
Onasemnogene Abeparvovec
22%
Brain Pseudotumor
22%
Cerebral Atrophy
22%
Newborn Screening
22%
Gross Motor Function Measure
21%
Pediatrics Patient
20%
Spasticity
20%
Tuberous Sclerosis
19%
Epilepsy in Children
19%
Blood Pressure
19%
Idiopathic Intracranial Hypertension
19%
Neurofibromatosis Type I
19%
Leukodystrophy
19%
Sequela
19%
Developmental Delay
18%
Childbirth
18%
Cerebellum Atrophy
16%
Muscle Tone
15%
Prevalence
15%
Leukoencephalopathy
14%
Lactic Acid
14%
Somatomedin C
14%
Symptom
14%
Early Diagnosis
14%
Neurologic Disease
13%
Bleeding
13%
Drug Resistant Epilepsy
13%